Login

Poseida Therapeutics, Inc. SEC Filings

Filed On Filing
15 May 2025 SCHEDULE 13G/A
14 Feb 2025 SCHEDULE 13G
07 Feb 2025 SCHEDULE 13G/A
07 Feb 2025 SCHEDULE 13G/A
21 Jan 2025 15-12G
15 Jan 2025 SCHEDULE 13G/A
13 Jan 2025 SCHEDULE 13D/A
10 Jan 2025 EFFECT
10 Jan 2025 EFFECT
10 Jan 2025 Form 4: Malin Life Sciences Holdings Ltd, 10% owner

Disposed of 11,835,673 shares (Tender Offer)

08 Jan 2025 S-8 POS
08 Jan 2025 S-8 POS
08 Jan 2025 S-8 POS
08 Jan 2025 S-8 POS
08 Jan 2025 S-8 POS
08 Jan 2025 POS AM
08 Jan 2025 POS AM
08 Jan 2025 Form 4: Amado Rafael, Director

Disposed of 58,950 shares (Tender Offer) · Disposed of 82,550 Stock Option (Right to Buy) (Disposition to Issuer)

08 Jan 2025 Form 4: Corning Luke, Director

Disposed of 58,950 shares (Tender Offer) · Disposed of 129,033 Stock Option (Right to Buy) (Disposition to Issuer)

08 Jan 2025 Form 4: Schmid John P., Director

Disposed of 58,950 shares (Tender Offer) · Disposed of 197,147 Stock Option (Right to Buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support